Free Trial

PMV Pharmaceuticals (PMVP) SEC Filings & 10K Form

PMV Pharmaceuticals logo
$1.57 -0.02 (-1.26%)
(As of 11/20/2024 ET)

Recent PMV Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/14/2024
11:24 AM
ArrowMark Colorado Holdings LLC (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
7:00 AM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
7:00 AM
PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/12/2024
4:59 PM
Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:00 PM
Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:00 AM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:00 AM
PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/16/2024
8:02 AM
PMV Pharmaceuticals (Subject)
Form SC TO-I
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
06/10/2024
3:43 PM
LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:44 PM
PMV Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:17 PM
FLOWERS KIRSTEN (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:21 PM
Gallagher Carol Giltner (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:22 PM
Heyman Richard A. (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:32 AM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:00 AM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:00 AM
PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
7:00 AM
PMV Pharmaceuticals (Filer)
Form DEF 14A
04/24/2024
7:01 AM
PMV Pharmaceuticals (Filer)
Form DEFA14A
04/24/2024
7:02 AM
PMV Pharmaceuticals (Filer)
Form ARS
04/09/2024
12:17 PM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
02/29/2024
3:05 PM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
3:05 PM
PMV Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
2:38 PM
ArrowMark Colorado Holdings LLC (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G
02/14/2024
8:18 AM
Avoro Capital Advisors LLC (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
6:52 AM
PMV Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
01/29/2024
2:26 PM
PMV Pharmaceuticals (Subject)
Form SC 13G/A
01/24/2024
8:01 AM
PMV Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/23/2024
8:07 AM
PMV Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/23/2024
8:40 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
01/22/2024
3:02 PM
Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:04 PM
Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:06 PM
Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:18 PM
Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/24/2023
3:38 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PMVP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners